Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 42Melanosis 3Carcinoma, Basal Cell 3Keratosis, Seborrheic 1Keratosis 1Facies 1Carcinoma 1

Interventions

Imiquimod 4tirbanibulin 3Cryotherapy 2methyl 5-aminolevulinate 1Tomography, Optical Coherence 1Sugars 1Ointments 1Lasers, Gas 1Fluorouracil 1BF-200 ALA 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Keratosis × 3-ingenyl angelate × Dermatologic × Clear all
NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Peplin

Phase 2 Completed
34 enrolled
Dermatologic

Keratosis, Melanosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡